Showing results (411-420 of 671) with videos related to

Sort By:
Pageof 68
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma PatientsEdwin R Parra, Carmen Behrens, Jaime Rodriguez-Canales, et al.
The Annals of Thoracic Surgery|September 25, 2019
Lymphovascular Invasion Is Associated With Mutational Burden and PD-L1 in Resected Lung CancerKyle G Mitchell, Marcelo V Negrao, Edwin R Parra, et al.
Journal of Cutaneous Pathology|March 19, 2019
Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14<sup>+</sup> and CD16<sup>+</sup> monocytes driving an innate immune responseJonathan L Curry, Alexandre Reuben, Robert Szczepaniak-Sloane, et al.
Experimental Hematology & Oncology|March 21, 2023
PD-L1<sup>+</sup> macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphomaRaphael E Steiner, Edwin R Parra, Francisco Vega, et al.
Endocrinology|March 31, 2011
Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer developmentWoo-Young Kim, Mi-Jung Kim, Hojin Moon, et al.
The Journal of Clinical Investigation|August 9, 2016
ZEB1 drives epithelial-to-mesenchymal transition in lung cancerJill E Larsen, Vaishnavi Nathan, Jihan K Osborne, et al.
Clinical Lung Cancer|August 9, 2020
Female Gender Predicts Augmented Immune Infiltration in Lung AdenocarcinomaCarmen Behrens, Pedro Rocha, Edwin R Parra, et al.
Plos One|May 5, 2012
Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humansCharles Lu, David J Stewart, J Jack Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2016
Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcomeSatyendra C Tripathi, Haley L Peters, Ayumu Taguchi, et al.
Cancer Research|May 20, 2016
IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung CancerMauricio S Caetano, Huiyuan Zhang, Amber M Cumpian, et al.
Pageof 68